FDA issued a Warning Letter to Tubilux Pharma Spa on 7/6/2017 as a result of this inspection.
483 Tubilux Pharma Spa Dec 2016
483 Tubilux Pharma Spa Dec 2016Milva Melendez FDA$119.00 - Available Now
FDA investigators audited the Tubilux Pharma Spa - Pomezia, Italy facility and issued inspectional observations (via FDA 483) on 09 Dec 2016.
Add To Cart
- Category: Human Drugs
- Inspection end: 09 Dec 2016
- Location: Pomezia, Italy
- FEI: 3003854110